Bookmark and Share


Recommendation for Temperature Monitoring during General Anesthesia

by MHAUS Staff

Wednesday, November 26, 2014 /

Tagged: Public Comment ·

Recommendation: MHAUS recommends core temperature monitoring for all patients given general anesthesia lasting more than 30 minutes. Appropriate sites for continuous electronic core temperature monitoring include the esophagus, nasopharynx, tympanic membrane (with probe in contact with the membrane), bladder, and the pulmonary artery. Background: Malignant hyperthermia (MH) is an inherited …

1 Comment · 776 words · est. read time: 4 minutes · Read and Comment »

Dantrolene In Treatment Of Hyperthermic Syndromes

by Guest Contributor

Monday, November 10, 2014 /

Tagged: General ·

Shonali Pawar, MD I would like to share some of my thoughts on a research project that I completed recently while a resident in Surgery at Saint Barnabas Medical Center in Livingston, NJ. I had no idea that I was embarking on a journey so different from any research that …

0 Comments · 939 words · est. read time: 5 minutes · Read and Comment »

Advances in Diagnostic Molecular Genetics and the Implications for Malignant Hyperthermia

by Dr. Henry Rosenberg MD, CPE

Tuesday, August 26, 2014 /

Tagged: General ·

Very recently, the Institute of Medicine, an independent, nonprofit, non-governmental prestigious "think tank" composed of eminent scholars published the proceedings of a roundtable discussion on "Translating Genomic-Based Research for Health".  In other words, "How do physicians and scientists make sense of the large amount of information that is derived from …

0 Comments · 1344 words · est. read time: 7 minutes · Read and Comment »

Malignant Hyperthermia Experts Get Ready To Discuss Ryanodex®

by MHAUS Staff

Friday, August 22, 2014 /

Tagged: General ·

Malignant Hyperthermia experts will discuss Ryanodex® and other topics at a planned meeting this September 20 and 21 in Chicago, Illinois. At the meeting MH experts will talk on how the administration of Ryanodex® might affect MHAUS’ Emergency Therapy for Malignant Hyperthermia now being used by ambulatory surgery centers, hospitals, …

1 Comment · 113 words · est. read time: 1 minute · Read and Comment »

Rare Disorder Roadmap to Testing Options and Answers

by Dianne Daugherty, MHAUS Executive Director

Tuesday, August 5, 2014 /

Tagged: General ·

Although malignant hyperthermia (MH) is an uncommon disorder, when it happens to you or your family member, it becomes a frequent and common topic of concern and animated conversation. Thus, when one of our family members requested the Malignant Hyperthermia Association of the United States (MHAUS) develop a resource to …

1 Comment · 642 words · est. read time: 3 minutes · Read and Comment »

European MH Group Meeting Blog

by Dr. Henry Rosenberg MD, CPE

Monday, June 16, 2014 /

Tagged: General ·

May 15-17, 2014 The European MH Group consisting of clinicians and scientists interested in and studying MH and related disorders met in the beautiful town of Wurzburg, Germany, in the northern part of Bavaria. Wurzburg was the home of Dr. Wilhelm Conrad Roentgen, who discovered x-rays and was the first …

0 Comments · 1443 words · est. read time: 7 minutes · Read and Comment »

The Malignant Hyperthermia Registry from an SRNA’s Point of View

by Guest Contributor

Friday, May 16, 2014 /

Tagged: General ·

I am currently a second year nurse anesthesia student at the University of Pittsburgh who had a wonderful opportunity to work alongside some of the most dedicated professionals I have ever met. I spent approximately 60 hours assisting at the North American Malignant Hyperthermia Registry (NAMHR) in Pittsburgh, PA as …

0 Comments · 642 words · est. read time: 3 minutes · Read and Comment »

Far Reaching New Information Concerning the Diagnosis and Management of MH and Exertional Heat Stroke

by Dr. Henry Rosenberg MD, CPE

Thursday, March 20, 2014 /

Tagged: General · Update on MH and MHAUS ·

The views expressed in this posting are mine alone and do not necessarily represent the views of other professionals or Board Members of MHAUS. A “new “ dantrolene?  In 1979 dantrolene was approved by the FDA for the treatment of Malignant Hyperthermia. Dantrium (dantrolene)  was developed by a small company …

5 Comments · 1315 words · est. read time: 7 minutes · Read and Comment »

President's Report

by Dr. Henry Rosenberg MD, CPE

Monday, October 28, 2013 /

Tagged: General · Update on MH and MHAUS ·

President’s Report October 2013 Henry Rosenberg MD  It has been some months since I last drafted a blog for the MH community.  It was not because there was little to report, but rather because I was occupied with a variety of tasks related to my “day job” as Director of …

0 Comments · 1692 words · est. read time: 8 minutes · Read and Comment »

What does it take to educate people about Malignant Hyperthermia (MH)?

by Sharon J. Hirshey Dirksen, Ph.D.

Thursday, June 20, 2013 /

Tagged: General ·

It is hard to believe that a year has passed since I stopped working for MHAUS and started to teach writing at the college level. So, when I was invited to write a blog about my experience working for MHAUS as Scientific Officer (from 2007-2012), I thought, that might be …

6 Comments · 1281 words · est. read time: 6 minutes · Read and Comment »